Adumb has no credibility, he works for Cramer. plus he actually wrote an article about short selling being good and interviewed a #$%$ hedge short seller. If you evaluate biotechs, why are you writing about short selling? unless you were defending promoting and endorsing short selling. a man with a political science degree evaluates biotechs, it is a total joke.
Similar to ARNA in that it has a fanatical following who are convinced it's gonna go big but how can you say it's similar beyond that point? Yes, fanatics could run it up again but bashes against ARNA no longer have a major effect and ARNA management is second to none. Belviq is an approved drug and so on.... imho, there's no "Similar".... just a daytrading possibility as the HEB fanatics "buy (a dying stock) on the dip"